Density	1.24±0.1 g/cm3 (20 ºC

没有数据	没有数据

Source	SDS/MSDS Samples
没有数据	没有数据

Synthetic Route

More

Name	CAS

More

Articles

Peer-Reviewed Papers

Evaluation of a multisubunit recombinant polymorphic membrane protein and major outer membrane protein T cell vaccine against Chlamydia muridarum genital infection in three strains of mice.Hong Yu et al.Vaccine, 32(36), 4672-4680 (2014-07-06) Dioctadecyldimethylammonium:monoolein nanocarriers for efficient in vitro gene silencing.Ana Cristina Norberto Oliveira et al.ACS applied materials & interfaces, 6(9), 6977-6989 (2014-04-10) Lipophilic quaternary ammonium salt acts as a mucosal adjuvant when co-administered by the nasal route with vaccine antigensKlinguer C, et al. Vaccine, 19(30), 4236-4244 (2001) Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR-Cas gene editing.Qiang Cheng et al.Nature nanotechnology, 15(4), 313-320 (2020-04-07) Chlamydia muridarum T cell antigens and adjuvants that induce protective immunity in mice.Hong Yu et al.Infection and immunity, 80(4), 1510-1518 (2012-02-01) Lipid nanoparticles for delivery of messenger RNA to the back of the eyePatel S, et al. J. Controlled Release, 303, 91-100 (2019) Liposomes and drug-in-cyclodextrin-in-liposomes formulations encapsulating 17β-estradiol: An innovative drug delivery system that prevents the activation of the membrane-initiated steroid signaling (MISS) of estrogen receptor α.Anne Gallez et al.International journal of pharmaceutics, 573, 118861-118861 (2019-11-26) Chlamydia muridarum T-cell antigens formulated with the adjuvant DDA/TDB induce immunity against infection that correlates with a high frequency of gamma interferon (IFN-gamma)/tumor necrosis factor alpha and IFN-gamma/interleukin-17 double-positive CD4+ T cells.Hong Yu et al.Infection and immunity, 78(5), 2272-2282 (2010-03-17) Lyoprotectant Optimization for the Freeze-Drying of Receptor-Targeted Trojan Horse Liposomes for Plasmid DNA Delivery.Hungyen Lee et al.Molecular pharmaceutics, 17(6), 2165-2174 (2020-04-22)

Remarks